Contribute to innovation in AI-enabled biomarker development through the application of quantitative image-based biomarkers, spatial biology approaches, multimodal data integration, and novel analytical methodologies. At Computational Pathology Munich (CPM), we make a significant contribution to high-performance, data-driven research and development. AstraZeneca's Enterprise AI organization is building the future of drug development, a fully integrated AI engine that connects data, technology, and expertise to accelerate breakthroughs across our portfolio. * Design and deliver proof-of-concept studies integrating computational pathology with imaging, blood biomarkers, genomics, proteomics, and clinical data to generate translational insights into disease biology, treatment response, and resistance mechanisms. * PhD in Biological Sciences, Computational Biology, Bioinformatics, ...
mehr